These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27892722)

  • 1. Present and future DNA vaccines for chronic hepatitis B treatment.
    Cova L
    Expert Opin Biol Ther; 2017 Feb; 17(2):185-195. PubMed ID: 27892722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The woodchuck: a model for therapeutic vaccination against hepadnaviral infection.
    Roggendorf M; Yang D; Lu M
    Pathol Biol (Paris); 2010 Aug; 58(4):308-14. PubMed ID: 20646874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.
    Kosinska AD; Zhang E; Johrden L; Liu J; Seiz PL; Zhang X; Ma Z; Kemper T; Fiedler M; Glebe D; Wildner O; Dittmer U; Lu M; Roggendorf M
    PLoS Pathog; 2013; 9(6):e1003391. PubMed ID: 23785279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.
    Yoon SK; Seo YB; Im SJ; Bae SH; Song MJ; You CR; Jang JW; Yang SH; Suh YS; Song JS; Kim BM; Kim CY; Jeong SH; Sung YC
    Liver Int; 2015 Mar; 35(3):805-15. PubMed ID: 24620920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck.
    Kosinska AD; Liu J; Lu M; Roggendorf M
    Med Microbiol Immunol; 2015 Feb; 204(1):103-14. PubMed ID: 25535101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
    Roggendorf M; Schulte I; Xu Y; Lu M
    J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase IIb trial of
    Yang FQ; Rao GR; Wang GQ; Li YQ; Xie Y; Zhang ZQ; Deng CL; Mao Q; Li J; Zhao W; Wang MR; Han T; Chen SJ; Pan C; Tan DM; Shang J; Zhang MX; Zhang YX; Yang JM; Chen GM
    World J Gastroenterol; 2017 Jan; 23(2):306-317. PubMed ID: 28127204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapies for chronic hepatitis B.
    Bitton Alaluf M; Shlomai A
    Liver Int; 2016 Jun; 36(6):775-82. PubMed ID: 26854115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control and Eradication Strategies of Hepatitis B Virus.
    Shih C; Chou SF; Yang CC; Huang JY; Choijilsuren G; Jhou RS
    Trends Microbiol; 2016 Sep; 24(9):739-749. PubMed ID: 27287929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein.
    Menne S; Tennant BC; Gerin JL; Cote PJ
    J Virol; 2007 Oct; 81(19):10614-24. PubMed ID: 17652398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future prevention and treatment of chronic hepatitis B infection.
    Seto WK; Fung J; Yuen MF; Lai CL
    J Clin Gastroenterol; 2012 Oct; 46(9):725-34. PubMed ID: 22914347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.
    Saade F; Buronfosse T; Guerret S; Pradat P; Chevallier M; Zoulim F; Jamard C; Cova L
    J Viral Hepat; 2013 Apr; 20(4):e56-65. PubMed ID: 23490390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances and challenges in the development of therapeutic DNA vaccines against hepatitis B virus infection.
    Cova L
    Curr Gene Ther; 2014; 14(3):149-60. PubMed ID: 24828255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
    Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM
    BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progress of therapeutic vaccines for treating chronic hepatitis B.
    Li J; Bao M; Ge J; Ren S; Zhou T; Qi F; Pu X; Dou J
    Hum Vaccin Immunother; 2017 May; 13(5):986-997. PubMed ID: 28118084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.
    Korba BE; Cote PJ; Menne S; Toshkov I; Baldwin BH; Wells FV; Tennant BC; Gerin JL
    Antivir Ther; 2004 Dec; 9(6):937-52. PubMed ID: 15651753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges.
    Michel ML; Deng Q; Mancini-Bourgine M
    J Hepatol; 2011 Jun; 54(6):1286-96. PubMed ID: 21238516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
    Lok AS
    J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.